Ensign Peak Advisors, Inc Legend Biotech Corp Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 9,050 shares of LEGN stock, worth $347,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,050
Previous 7,850
15.29%
Holding current value
$347,701
Previous $255,000
20.39%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
73.3MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$266 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$259 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$230 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$220 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$144 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.43B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...